IHC 4-8 ANTIGENS

The IHC – 4 to 8 Antigens test is an advanced multi-marker immunohistochemistry (IHC) diagnostic panel designed to detect four to eight specific antigen markers simultaneously in a tissue sample. Immunohistochemistry is a highly specialized laboratory technique that uses antibodies to identify proteins expressed by normal or abnormal cells, allowing pathologists to accurately classify tissue abnormalities and diagnose diseases.

This multi-marker panel is especially valuable for complex pathological cases where multiple biomarkers are required to determine tissue origin, classify tumors, differentiate benign from malignant lesions, and confirm challenging diagnoses. By analyzing several markers in one comprehensive test, pathologists can obtain a complete tissue profile with greater accuracy and efficiency.

The simultaneous detection of multiple antigens helps reduce diagnostic uncertainty and provides clinicians with detailed information needed for personalized treatment planning.

Benefits of the Test

The IHC 4 to 8 Antigens test offers several important clinical benefits:

• Detects multiple tissue markers simultaneously
• Provides comprehensive tissue profiling
• Improves diagnostic accuracy and confidence
• Helps identify tumor origin and subtype
• Assists in evaluating difficult pathology cases
• Supports precise treatment planning

This test is essential when advanced molecular tissue characterization is required.

Why Doctors Recommend This Test

Doctors recommend the IHC 4 to 8 Antigens panel when detailed tissue analysis is needed for complex diagnosis.

It is commonly advised for:

• Complex tumor tissue evaluation
• Identification of metastatic tumor origin
• Differentiation of benign and malignant lesions
• Advanced cancer classification
• Difficult pathology confirmation cases
• Comprehensive oncology diagnostic workup

The results help pathologists provide accurate diagnosis and guide effective treatment decisions.

Preparation Before Test

No special preparation is required from the patient. The test is performed on previously collected tissue biopsy or surgical specimens obtained during routine medical procedures.

Normal Reporting Time

The usual reporting time for the IHC 4 to 8 Antigens panel is 3 to 7 working days, depending on the number of markers tested and laboratory workflow.

Who Should Take This Test

This test is recommended for:

• Patients undergoing complex tissue biopsy evaluation
• Individuals with suspected advanced tumors
• Patients requiring detailed multi-marker confirmation
• Cases needing comprehensive tissue classification
• Oncology patients requiring precision diagnosis for treatment planning

The IHC 4 to 8 Antigens test is a critical diagnostic tool in modern pathology. It provides comprehensive multi-marker tissue analysis for accurate diagnosis, improved tumor classification, and highly personalized treatment guidance. Early and precise diagnosis significantly improves patient outcomes and clinical management.